Avaleht › 2. tüüpi diabeet › California
2. tüüpi diabeet kliinilised uuringud osariigis California
67 uuringut haiguse 2. tüüpi diabeet jaoks otsivad osalejaid osariigis California.
Linnad osariigis California
- San Diego17 uuringut
- Los Angeles16 uuringut
- Long Beach11 uuringut
- Concord10 uuringut
- Sacramento9 uuringut
- Simi Valley8 uuringut
- El Cajon7 uuringut
- Mountain View7 uuringut
- Santa Clarita6 uuringut
- Escondido6 uuringut
- Chula Vista6 uuringut
- Pomona6 uuringut
- Roseville5 uuringut
- Ontario4 uuringut
- Westminster4 uuringut
- West Covina4 uuringut
- Torrance4 uuringut
- Lancaster4 uuringut
- Santa Monica4 uuringut
- San Bernardino4 uuringut
- Huntington Beach4 uuringut
- San Francisco3 uuringut
- Santa Barbara3 uuringut
- South Gate3 uuringut
- Carson3 uuringut
- Tustin3 uuringut
Ametlik uuringutekst (inglise keeles)
Efficacy of mHealth Apps for Health in a Low-income, Type II Diabetic, Hispanic Population
- San Diego State University, San Diego
VärbamineTerved vabatahtlikud oodatud
Vanused 18–64 · Kõik sood · Uuendatud 2. okt 2026 · NCT05279729Efficacy of Using Mobile Health Applications for Health
- San Diego State University, San Diego
VärbamineTerved vabatahtlikud oodatud
Vanused 18–64 · Kõik sood · Uuendatud 2. okt 2026 · NCT05589155A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Thrive Clinical Research Group, Glendora
VärbamineFaas 2
Vanused 18 ja vanemad · Kõik sood · Uuendatud 30. sept 2026 · NCT07783802Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema
- Ark Clinical Research, Fountain Valley
- Thrive Clinical Research Group, Glendora
- Scripps Whittier Diabetes Inst, La Jolla
- ja veel 5
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 30. sept 2026 · NCT07817251EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- National Heart Institute, Beverly Hills
- Hope Clinical Research, Canoga Park
- John Muir Physician Network Clinical Research Center, Concord
- ja veel 11
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 30. sept 2026 · NCT07064473A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
- San Fernando Valley Health, Canoga Park
- John Muir Physician Network Clinical Research Center, Concord
- Neighborhood Healthcare - Escondido, Escondido
- ja veel 9
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 30. sept 2026 · NCT07754461A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
- Cardiovascular Research Foundation of Southern California, Beverly Hills
- Amicis Research: Beverly Hills, Beverly Hills
- Valiance Clinical Research - Canoga Park, Canoga Park
- ja veel 21
VärbamineTerved vabatahtlikud oodatud
Vanused 55 ja vanemad · Kõik sood · Uuendatud 28. sept 2026 · NCT06112418Using Continuous Glucose Monitoring to Quantify the Effects of NOURISH's Culturally Modified Meals on Asian Americans With Type 2 Diabetes
- Stanford University, Stanford
Värbamine
Vanused 18 ja vanemad · Kõik sood · Uuendatud 28. sept 2026 · NCT06836479A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- San Fernando Valley Health Institute, Canoga Park
- Headlands Research California, LLC, Escondido
- ImmuniMet, LLC, Modesto
- ja veel 4
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 28. sept 2026 · NCT07595549A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- Research Site, Escondido
- Research Site, Lincoln
- Research Site, Walnut Creek
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 25. sept 2026 · NCT07776509A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- San Fernando Valley Health Institute, Canoga Park
- AMCR Institute, Escondido
- NorCal Medical Research, Inc, Greenbrae
- ja veel 6
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 22. sept 2026 · NCT07282600A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, Bakersfield
- Research Site, Gardena
- Research Site, Lincoln
- ja veel 2
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 22. sept 2026 · NCT07784270A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Banning
- AURORA-2 Clinical Site, Chula Vista
- AURORA-2 Clinical Site, Covina
- ja veel 6
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 16. sept 2026 · NCT07743450A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants
- Research Site, Glendale
VärbamineFaas 1Terved vabatahtlikud oodatud
Vanused 18–55 · Kõik sood · Uuendatud 16. sept 2026 · NCT07723833A Study to Evaluate ALN-4324 on Insulin Sensitivity in Adults With Type 2 Diabetes Mellitus
- Clinical Trial Site, Chula Vista
VärbamineFaas 2
Vanused 18–65 · Kõik sood · Uuendatud 16. sept 2026 · NCT07465224A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
- Core Healthcare Group, Cerritos
- Ark Clinical Research - Long Beach, Long Beach
- Flourish Research - Walnut Creek - PPDS, Walnut Creek
VärbamineFaas 2
Vanused 18–75 · Kõik sood · Uuendatud 15. sept 2026 · NCT07340320A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Orange County Research Center, Lake Forest
- Ark Clinical Research, Long Beach
- Catalina Research Institute, LLC, Montclair
- ja veel 3
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 14. sept 2026 · NCT07351058Pregnancy and Postpartum Breastfeeding Support for Patients With Gestational Diabetes
- UC Davis Medical Center, Sacramento
VärbamineVaatlusuuringTerved vabatahtlikud oodatud
Vanused 18 ja vanemad · Kõik sood · Uuendatud 14. sept 2026 · NCT07176793A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
- Wolverine Clinical Trials, Santa Ana
VärbamineFaas 2
Vanused 18–75 · Kõik sood · Uuendatud 14. sept 2026 · NCT06897475A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes
- First Valley Medical Group, Lancaster
- Torrance Clinical Research Institute, Inc., Lomita
- Ark Clinical Research, Long Beach
- ja veel 3
VärbamineFaas 2
Vanused 18–75 · Kõik sood · Uuendatud 11. sept 2026 · NCT07415954Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
- AME Clinical Research, Huntington Beach
- Amicis Research Center, Northridge
- FOMAT - Vista del Mar Medical Group, Oxnard
- ja veel 6
VärbamineFaas 2
Vanused 18–80 · Kõik sood · Uuendatud 11. sept 2026 · NCT07271186A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
- Ark Clinical Research, Fountain Valley
- Ark Clinical Research, Long Beach
- Los Angeles Institute for Metabolic Research, Los Angeles
- ja veel 1
VärbamineFaas 2
Vanused 18–75 · Kõik sood · Uuendatud 11. sept 2026 · NCT07668388A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
- Research Site, Covina
- Research Site, Encinitas
- Research Site, Garden Grove
- ja veel 4
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 9. sept 2026 · NCT07662213Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
- Ark Clinical Research - Fountain Valley, Fountain Valley
- Velocity Clinical Research, Huntington Park, Huntington Park
- Velocity Clinical Research - Gardena, La Mesa
- ja veel 4
VärbamineFaas 2
Vanused 18 ja vanemad · Kõik sood · Uuendatud 9. sept 2026 · NCT07296484Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
- San Fernando Valley Health Institute, Canoga Park
- Core Healthcare Group, Cerritos
- Velocity Clinical Research Chula Vista, Chula Vista
- ja veel 1
VärbamineFaas 3
Vanused 18–99 · Kõik sood · Uuendatud 3. sept 2026 · NCT07684144A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
- Research Site, Concord
- Research Site, Sacramento
- Research Site, Victorville
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 2. sept 2026 · NCT07662135AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
- First Valley Medical Group, Lancaster
- Headlands Research CTR Lincoln, Lincoln
- Torrance Clin Res Inst, Inc., Lomita
- ja veel 6
VärbamineFaas 3
Vanused 45 ja vanemad · Kõik sood · Uuendatud 1. sept 2026 · NCT07797335A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
- Research Site, Bakersfield
- Research Site, Los Angeles
- Research Site, Ontario
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 31. aug 2026 · NCT07662109A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
- Research Site, Lomita
- Research Site, Los Alamitos
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 31. aug 2026 · NCT07662044A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies
- Research Site, Lincoln
VärbamineVaatlusuuring
Vanused 18 ja vanemad · Kõik sood · Uuendatud 25. aug 2026 · NCT07606066A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of Creatinine in a Non Interventional Cohort
- Research Site, Glendale
VärbamineFaas 1Terved vabatahtlikud oodatud
Vanused 18–75 · Kõik sood · Uuendatud 12. aug 2026 · NCT07024823Food Insecurity Reduction & Strategy Team
- Stanford Medicine, Palo Alto
Värbamine
Vanused 18 ja vanemad · Kõik sood · Uuendatud 11. aug 2026 · NCT06329375A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
- Division of Endocrinology, Diabetes, and Metabolism, Los Angeles
- UCLA Mattel Children's Hospital, Los Angeles
- University of California, San Francisco, San Francisco
VärbamineFaas 3
Vanused 10–17 · Kõik sood · Uuendatud 7. aug 2026 · NCT06739122Safer Aging With Diabetes Monitoring
- Kaiser Permanente Sacramento, Sacramento
Värbamine
Vanused 75 ja vanemad · Kõik sood · Uuendatud 4. aug 2026 · NCT06296485A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin
- Research Site, Sacramento
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 4. aug 2026 · NCT07664553Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System
- University of Southern California, Los Angeles
- Sansum Diabetes Research Institute, Santa Barbara
Värbamine
Vanused 14–75 · Kõik sood · Uuendatud 3. aug 2026 · NCT07579702A Trial Evaluating AMG 127 in Healthy Participants and Participants With Type 2 Diabetes Mellitus
- Orange County Research Center, Lake Forest
VärbamineFaas 1Terved vabatahtlikud oodatud
Vanused 18–75 · Kõik sood · Uuendatud 3. aug 2026 · NCT07590193Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
- University of Southern California, Los Angeles
- HOAG, Newport Beach
- Sansum Diabetes Research Institute, Santa Barbara
- ja veel 1
Värbamine
Vanused 18–75 · Kõik sood · Uuendatud 3. aug 2026 · NCT07521475Time Restricted Eating in Patients With Microalbuminuria
- Altman Clinical and Translational Research Institute, La Jolla
VärbamineFaas 1
Vanused 18–75 · Kõik sood · Uuendatud 14. juuli 2026 · NCT06884059CGM for Management of Type 2 Diabetes in Pregnancy
- University of California at San Diego, San Diego
Värbamine
Vanused 18–50 · Naised · Uuendatud 29. juuni 2026 · NCT06628453Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.